298 related articles for article (PubMed ID: 9315421)
1. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
Ghosh D; Nayak NR; Sengupta J
Contraception; 1997 Aug; 56(2):117-22. PubMed ID: 9315421
[TBL] [Abstract][Full Text] [Related]
2. Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey.
Nayak NR; Ghosh D; Lasley BL; Sengupta J
Contraception; 1997 Feb; 55(2):103-14. PubMed ID: 9071520
[TBL] [Abstract][Full Text] [Related]
3. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
4. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
5. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
Nayak NR; Sengupta J; Ghosh D
Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
7. Early luteal phase administration of mifepristone inhibits preimplantation embryo development and viability in the rhesus monkey.
Ghosh D; Kumar PG; Sengupta J
Hum Reprod; 1997 Mar; 12(3):575-82. PubMed ID: 9130762
[TBL] [Abstract][Full Text] [Related]
8. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
[TBL] [Abstract][Full Text] [Related]
9. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M
Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of RU 486.
Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
[TBL] [Abstract][Full Text] [Related]
11. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
12. Preimplantation embryo morphology following early luteal phase anti-nidatory treatment with mifepristone (RU486) in the rhesus monkey.
Ghosh D; Lalitkumar PG; Wong VJ; Hendrickx AG; Sengupta J
Hum Reprod; 2000 Jan; 15(1):180-8. PubMed ID: 10611210
[TBL] [Abstract][Full Text] [Related]
13. Fertility impairment after mifepristone treatment to rats at proestrus. Actions on the hypothalamic-hypophyseal-ovarian axis.
Telleria CM; Mezzadri MR; Deis RP
Contraception; 1997 Oct; 56(4):267-74. PubMed ID: 9408709
[TBL] [Abstract][Full Text] [Related]
14. Anti-implantation activity of antiestrogens and mifepristone.
Dao B; Vanage G; Marshall A; Bardin CW; Koide SS
Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
[TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of Le(y) oligosaccharide in endometrium during menstrual cycle and effect of early luteal phase mifepristone administration on its expression in implantation stage endometrium of the rhesus monkey.
Ghosh D; Liu N; Zhu ZM; Sengupta J
Hum Reprod; 1998 May; 13(5):1374-9. PubMed ID: 9647575
[TBL] [Abstract][Full Text] [Related]
16. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
17. Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey.
Ghosh D; Sengupta J
Hum Reprod; 1993 Apr; 8(4):552-8. PubMed ID: 8501184
[TBL] [Abstract][Full Text] [Related]
18. Luteal phase contraception with mifepristone (RU 486) in the rhesus monkey.
Ghosh D; De P; Sengupta J
Indian J Physiol Pharmacol; 1994 Jan; 38(1):17-22. PubMed ID: 8132238
[TBL] [Abstract][Full Text] [Related]
19. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
20. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations.
Gemzell-Danielsson K; Hamberg M
Hum Reprod; 1994 Sep; 9(9):1626-30. PubMed ID: 7836511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]